SI1976521T1 - Podjezično fentanilno pršilo - Google Patents
Podjezično fentanilno pršiloInfo
- Publication number
- SI1976521T1 SI1976521T1 SI200731630T SI200731630T SI1976521T1 SI 1976521 T1 SI1976521 T1 SI 1976521T1 SI 200731630 T SI200731630 T SI 200731630T SI 200731630 T SI200731630 T SI 200731630T SI 1976521 T1 SI1976521 T1 SI 1976521T1
- Authority
- SI
- Slovenia
- Prior art keywords
- sublingual fentanyl
- fentanyl spray
- spray
- sublingual
- fentanyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76205706P | 2006-01-25 | 2006-01-25 | |
EP07762549.9A EP1976521B1 (en) | 2006-01-25 | 2007-01-25 | Sublingual fentanyl spray |
PCT/US2007/002163 WO2007087431A2 (en) | 2006-01-25 | 2007-01-25 | Sublingual fentanyl spray |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1976521T1 true SI1976521T1 (sl) | 2015-06-30 |
Family
ID=38309867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200731630T SI1976521T1 (sl) | 2006-01-25 | 2007-01-25 | Podjezično fentanilno pršilo |
Country Status (16)
Country | Link |
---|---|
US (6) | US8486972B2 (sl) |
EP (2) | EP1976521B1 (sl) |
JP (3) | JP5241514B2 (sl) |
CN (1) | CN101378735B (sl) |
AU (1) | AU2007208229B2 (sl) |
BR (1) | BRPI0707235B8 (sl) |
CA (1) | CA2637672C (sl) |
DK (1) | DK1976521T3 (sl) |
ES (1) | ES2535233T3 (sl) |
MX (2) | MX2008009522A (sl) |
NZ (1) | NZ569949A (sl) |
PL (1) | PL1976521T3 (sl) |
PT (1) | PT1976521E (sl) |
RU (1) | RU2432950C2 (sl) |
SI (1) | SI1976521T1 (sl) |
WO (1) | WO2007087431A2 (sl) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA77398C2 (en) * | 2000-07-31 | 2006-12-15 | Nycomed Danmark As | Fentanyl composition for intranasal administration |
PL1976521T3 (pl) | 2006-01-25 | 2015-10-30 | Insys Therapeutics Inc | Spray fentanylu do podawania podjęzykowego |
US8210167B2 (en) * | 2007-03-02 | 2012-07-03 | Corbco, Inc. | Manually operated monodose nasal sprayer |
US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
ES2668366T3 (es) | 2007-08-02 | 2018-05-17 | Insys Development Company, Inc. | Pulverización sublingual de fentanilo |
GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
PL2244737T3 (pl) * | 2008-01-22 | 2020-05-18 | The Board Of Regents Of The University Of Texas System | Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu |
US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
SG174157A1 (en) * | 2009-02-26 | 2011-10-28 | Teikoku Pharma Usa Inc | Narcotic emulsion formulations for treatment of cancer pain |
GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
SG175160A1 (en) * | 2009-04-23 | 2011-11-28 | Londonpharma Ltd | Sublingual pharmaceutical composition comprising a neutral oil |
US20110021588A1 (en) * | 2009-05-15 | 2011-01-27 | Recro Pharma, Inc. | Sublingual dexmeditomidine compositions and methods of use thereof |
WO2011028629A1 (en) * | 2009-08-26 | 2011-03-10 | Nuvo Research Inc. | Pharmaceutical formulations and methods of use |
BR112012012315A2 (pt) * | 2009-11-23 | 2018-10-16 | Cipla Ltd | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica |
US20120295893A1 (en) * | 2009-12-14 | 2012-11-22 | Coeruleus Ltd. | Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs |
GB2481619B (en) * | 2010-06-30 | 2012-06-20 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
US8939943B2 (en) | 2011-01-26 | 2015-01-27 | Kaleo, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
US8627816B2 (en) | 2011-02-28 | 2014-01-14 | Intelliject, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
GB2487007B (en) * | 2012-03-19 | 2013-06-05 | Londonpharma Ltd | COC containers and delivery devices for the sublingual administration of opioids |
US9839611B2 (en) | 2013-09-10 | 2017-12-12 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
JP2016529328A (ja) * | 2013-09-10 | 2016-09-23 | インシス・ファーマ・インコーポレーテッド | 舌下ブプレノルフィンスプレー |
US9918981B2 (en) | 2013-09-10 | 2018-03-20 | Insys Development Company, Inc. | Liquid buprenorphine formulations |
US9867818B2 (en) | 2013-09-10 | 2018-01-16 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
US9566233B2 (en) | 2013-11-14 | 2017-02-14 | Insys Development Company, Inc. | Ondansetron sublingual spray formulation |
US9855234B2 (en) * | 2014-07-08 | 2018-01-02 | Insys Development Company, Inc. | Diclofenac sublingual spray |
US10617686B2 (en) * | 2014-07-08 | 2020-04-14 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
US20160199294A1 (en) * | 2014-07-08 | 2016-07-14 | Insys Development Company, Inc. | Sublingual naloxone spray |
US9642848B2 (en) * | 2014-07-08 | 2017-05-09 | Insys Development Company, Inc. | Sublingual naloxone spray |
US10722510B2 (en) * | 2014-07-08 | 2020-07-28 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
US10441538B2 (en) * | 2014-07-08 | 2019-10-15 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
US9517307B2 (en) | 2014-07-18 | 2016-12-13 | Kaleo, Inc. | Devices and methods for delivering opioid antagonists including formulations for naloxone |
US10172833B2 (en) | 2015-08-11 | 2019-01-08 | Insys Development Company, Inc. | Sublingual ondansetron spray |
CN109562096A (zh) * | 2016-04-13 | 2019-04-02 | 内布拉斯加大学董事会 | 施用树脂毒素的方法和用树脂毒素治疗心血管疾病的方法 |
US20170340557A1 (en) * | 2016-05-27 | 2017-11-30 | Insys Development Company, Inc. | Sublingual fentanyl formulations containing a permeation enhancer |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244478A (en) | 1979-06-27 | 1981-01-13 | Mpl, Inc. | Closure assembly for unit dose vial |
GB8900267D0 (en) | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
US5219083A (en) | 1992-04-02 | 1993-06-15 | Sterling Winthrop Inc. | Stopper for reduction of particulate matter |
DE69414710T2 (de) | 1993-08-10 | 1999-04-08 | Boots Co Ltd | Spruehformulierung mit kuehleffekt |
ATE223202T1 (de) | 1994-09-30 | 2002-09-15 | Mika Pharma Ges Fuer Die Entwi | Pharmazeutische zusammensetzung |
US20030082107A1 (en) | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
US20050281752A1 (en) | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20030077228A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders |
WO1999016417A1 (en) | 1997-10-01 | 1999-04-08 | Flemington Pharmaceutical Corporation | Buccal, polar and non-polar spray or capsule |
US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20050287075A1 (en) | 1997-10-01 | 2005-12-29 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20050002867A1 (en) | 1997-10-01 | 2005-01-06 | Novadel Pharma Inc. | Buccal, polar and non-polar sprays containing propofol |
US20040141923A1 (en) | 1997-10-01 | 2004-07-22 | Dugger Harry A. | Buccal, polar and non-polar spray containing alprazolam |
US20030095926A1 (en) | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
US20090162300A1 (en) | 1997-10-01 | 2009-06-25 | Dugger Iii Harry A | Buccal, polar and non-polar spray containing alprazolam |
US20040136913A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing sumatriptan |
US20030190286A1 (en) | 1997-10-01 | 2003-10-09 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
US20030095927A1 (en) | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
US20050163719A1 (en) | 1997-10-01 | 2005-07-28 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing diazepam |
US20040136915A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing atropine |
US20030077229A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US20050180923A1 (en) | 1997-10-01 | 2005-08-18 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing testosterone |
US20030095925A1 (en) | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
AU2879100A (en) * | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
US20030190290A1 (en) * | 2000-06-22 | 2003-10-09 | Calvin Ross | Pharmaceutical compositions |
US20020160991A1 (en) | 2000-12-04 | 2002-10-31 | Liming Shao | Orally-bioavailable formulations of fentanyl and congeners thereof |
WO2003045357A1 (en) | 2001-11-27 | 2003-06-05 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
US6946150B2 (en) | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
DK1599186T3 (da) * | 2003-02-24 | 2013-07-08 | Pharmaceutical Productions Inc | System til administration af transmukalt lægemiddel |
EP1608372A2 (en) * | 2003-03-11 | 2005-12-28 | Arakis Ltd. | Compositions containing fentanyl |
US20060062812A1 (en) * | 2003-03-11 | 2006-03-23 | Calvin Ross | Novel compositions |
GB0305579D0 (en) * | 2003-03-11 | 2003-04-16 | Dallas Burston Ltd | Pharmaceutical compositions |
GB0514043D0 (en) | 2005-07-08 | 2005-08-17 | Arakis Ltd | Fentanyl formulation |
US20070124554A1 (en) * | 2005-10-28 | 2007-05-31 | Honeywell International Inc. | Global memory for a rapidio network |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
PL1976521T3 (pl) | 2006-01-25 | 2015-10-30 | Insys Therapeutics Inc | Spray fentanylu do podawania podjęzykowego |
ES2668366T3 (es) * | 2007-08-02 | 2018-05-17 | Insys Development Company, Inc. | Pulverización sublingual de fentanilo |
-
2007
- 2007-01-25 PL PL07762549T patent/PL1976521T3/pl unknown
- 2007-01-25 EP EP07762549.9A patent/EP1976521B1/en not_active Not-in-force
- 2007-01-25 JP JP2008552436A patent/JP5241514B2/ja active Active
- 2007-01-25 RU RU2008130763/15A patent/RU2432950C2/ru not_active Application Discontinuation
- 2007-01-25 US US11/698,739 patent/US8486972B2/en active Active
- 2007-01-25 NZ NZ569949A patent/NZ569949A/en not_active IP Right Cessation
- 2007-01-25 PT PT77625499T patent/PT1976521E/pt unknown
- 2007-01-25 CN CN200780003555XA patent/CN101378735B/zh active Active
- 2007-01-25 BR BRPI0707235A patent/BRPI0707235B8/pt not_active IP Right Cessation
- 2007-01-25 WO PCT/US2007/002163 patent/WO2007087431A2/en active Application Filing
- 2007-01-25 DK DK07762549T patent/DK1976521T3/en active
- 2007-01-25 SI SI200731630T patent/SI1976521T1/sl unknown
- 2007-01-25 ES ES07762549.9T patent/ES2535233T3/es active Active
- 2007-01-25 CA CA2637672A patent/CA2637672C/en not_active Expired - Fee Related
- 2007-01-25 AU AU2007208229A patent/AU2007208229B2/en not_active Ceased
- 2007-01-25 EP EP13172985.7A patent/EP2641595A1/en not_active Withdrawn
- 2007-01-25 MX MX2008009522A patent/MX2008009522A/es active IP Right Grant
-
2008
- 2008-07-24 MX MX2020008616A patent/MX2020008616A/es unknown
-
2012
- 2012-11-22 JP JP2012256454A patent/JP5630877B2/ja active Active
-
2013
- 2013-03-22 JP JP2013059447A patent/JP2013127003A/ja active Pending
- 2013-05-15 US US13/895,124 patent/US8835460B2/en not_active Expired - Fee Related
-
2014
- 2014-07-31 US US14/448,720 patent/US9289387B2/en active Active
-
2016
- 2016-02-12 US US15/042,999 patent/US9642797B2/en active Active
-
2017
- 2017-04-04 US US15/478,430 patent/US10016403B2/en not_active Expired - Fee Related
-
2018
- 2018-06-27 US US16/019,941 patent/US20180303813A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1976521A4 (en) | SUBLINGUAL FENTANYL SPRAY | |
PL2180844T3 (pl) | Rozpylacz podjęzykowy z fentanylem | |
IL195248A0 (en) | Atomiser | |
GB0613955D0 (en) | Controller | |
DE602007008470D1 (en) | Off | |
EP1973612A4 (en) | AUTOMATIC EXTINGUISHER HEAD | |
GB0614137D0 (en) | Spray device | |
GB0616226D0 (en) | Processes | |
EG25598A (en) | Casting nozzle | |
GB0625687D0 (en) | Spray device | |
GB0716905D0 (en) | Nozzle | |
GB0620727D0 (en) | Spray masks | |
EP2001096A4 (en) | CONTROL | |
GB0609434D0 (en) | Spray nozzle | |
GB0617808D0 (en) | Nozzle | |
GB2443193B (en) | Railing | |
GB0611418D0 (en) | Improved spray head for ablutionary applicances | |
GB201000798D0 (en) | Poly-TLR antagonists | |
GB2434853B (en) | Spray device | |
GB0607667D0 (en) | Spray nozzle | |
EP1983874A4 (en) | BUSE | |
GB0621406D0 (en) | Kirby | |
GB0605740D0 (en) | Spray | |
AU309692S (en) | Spray can | |
GB0605165D0 (en) | Key spray |